A US based emerging biopharma recognized that one of their anti-viral therapeutics being developed for a different indication might also help in the fight against the Coronavirus, COVID-19. Due to the emergency of the global pandemic they knew they had to react fast to meet the challenge but didn’t have the internal resources available.
Emergency Response: Getting Ahead of The Competitors
Within a rapidly evolving regulatory scene, medical devices are under high scrutiny. Regulatory requirements are currently being reinforced, in particular to ensure patient safety.